ArticleCancer medicine2024

Clinical Outcome of Induction Treatment in the Era of Novel Agents and the Impact of the Number of High-Risk Cytogenetic Abnormalities (HRA) on Prognosis of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Insights From a Multicenter Study.

Dong Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.